Bright idea: LED lighting may improve healthcare settings

Researchers from the Center for Lighting Enabled Systems & Applications (LESA) at Rensselaer Polytechnic Institute with the Illumination Engineering Society (IES) have released a white paper on their workshop that explored pathways to promote the adoption of lighting systems in healthcare environments.

"Today, the field of lighting and healthcare is undergoing rapid development," said Robert F. Karlicek Jr., LESA director, who also serves as a professor in the Department of Electrical, Computer and Systems Engineering at Rensselaer. "As research continues to build the link between lighting spectral power distributions and wellness, LED lighting technology strives to bring new healthy lighting to market. Often commercialization in this capacity happens without establishing the clinical data to demonstrate a value-added benefit for patients or the providers, or a defined return on investment for the healthcare industry."

As healthcare embraces the role that light and lighting could play in improving healthcare outcomes and providing a healthy work environment, researchers participated in a workshop to explore and define how adopting lighting system could benefit. The workshop, sponsored by LESA and IES, included lighting and human health researchers, healthy-lighting design experts, senior representatives from healthcare standards organizations and healthcare providers. They began discussions with stakeholders on the changes to current healthcare lighting.

"It has long been known that lighting can impact human health and wellness," said Brian Liebel, director of technical standards at IES. "Research continues to refine the precise role of light spectrum, intensity, and timing on the scope of patient outcomes, and on healthcare worker productivity. But more research is required to provide the evidence necessary for new, modern standards for lighting systems in healthcare and eldercare markets."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.